(Q45977906)
Statements
1 reference
Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry. (English)
1 reference
1 reference
A Haouala
1 reference
B Zanolari
1 reference
B Rochat
1 reference
M Montemurro
1 reference
K Zaman
1 reference
M A Duchosal
1 reference
H B Ris
1 reference
S Leyvraz
1 reference
L A Decosterd
1 reference
13 May 2009
1 reference
877
1 reference
22
1 reference
1982-1996
1 reference